The eye has been described as an immunologically privileged site where immunity is purely expressed. It has been demonstrated that administration of antigen into the eye induces only a weak immune response. However, the anterior part of the eye represents an important protective barrier against pathogens and other harmful invaders from the outer environment. Therefore, effective immune mechanisms, which operate locally, need to be present there. Because the cornea has been shown to be a potent producer of various cytokines and other molecules with immunomodulatory properties, we investigated a possible regulatory role for the individual corneal cell types on cytokine production by activated T cells. Mouse spleen cells were stimulated with the T cell mitogen concanavalin A in the presence of either corneal explants or cells of corneal epithelial or endothelial cell lines and the production of T helper 1 (Th1) or Th2 cytokines was determined by enzyme-linked immunosorbent assay (ELISA) or reverse transcription-polymerase chain reaction (RT-PCR). We found that the cornea possesses the ability to inhibit, in a dose-dependent manner, production of the inhibitory and anti-inflammatory cytokines interleukin (IL)-4 and IL-10 by activated T cells. The production of cytokines associated with protective immunity [IL-2, IL-1beta, interferon (IFN)-gamma ] was not inhibited under the same conditions. Corneal explants deprived of epithelial and endothelial cells retained the ability to suppress production of anti-inflammatory cytokines. This suppression was mediated by a factor produced by corneal stromal cells and occurred at the level of cytokine gene expression. We suggest that by this mechanism the cornea can potentiate a local expression of protective immune reactions in the anterior segment of the eye.

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic

See more in PubMed

Medawar PB. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948;29:58–69. PubMed PMC

Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol. 1977;25:1–54. PubMed

Ferguson TA, Green DR, Griffith TS. Cell death and immune privilege. Int Rev Immunol. 2002;21:153–72. PubMed

Kaplan HJ, Streilein JW. Immune response to immunization via the anterior chamber of the eye. I. F1 lymphocyte-induced immune deviation. J Immunol. 1977;118:809–14. PubMed

Stein-Streilein J, Streilein JW. Anterior chamber-associted immune deviation (ACAID): regulation, biological relevance, and implication for therapy. Int Rev Immunol. 2002;21:123–52. PubMed

Streilein JW, Stein-Streilein J. Does innate immune privilege exist? J Leukoc Biol. 2000;67:479–87. PubMed

Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189–92. PubMed

Lee HO, Herndon JM, Barreiro R, Griffith TS, Ferguson TA. TRAIL: a mechanism of tumor surveillance in an immune privileged site. J Immunol. 2002;169:4739–44. PubMed

Skelsey ME, Mellon J, Niederkorn JY. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol. 2001;166:4327–33. PubMed

Taylor AW. Immunoregulation of the ocular effector responses by soluble factors in aqueous humor. Reg Immunol. 1994;6:52–7.

Niederkorn JY. The immune privilege of corneal allografts. Transplantation. 1999;67:1503–8. PubMed

Sonoda A, Sonoda Y, Muramatu R, Streilein JW, Usui M. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts. Invest Ophthalmol Vis Sci. 2000;41:790–808. PubMed

Holáň V, Hašková Z, Filipec M. Transplantation immunity and tolerance in the eye. Rejection and acceptance of orthotopic corneal allografts in mice. Transplantation. 1996;62:1050–4. PubMed

Dighiero P, Behar-Cohen F, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokines stimulation. Invest Ophthalmol Vis Sci. 1997;38:2045–52. PubMed

O'Brien WJ, Heimann T, Tsao LS, Seet BT, McFadden G, Taylor JL. Regulation of nitric oxide synthase 2 in rabbit corneal cells. Invest Ophthalmol Vis Sci. 2001;42:713–9. PubMed

Holáň V, Krulová M, Zajícová A, Pindjaková J. Nitric oxide as a regulatory and effector molecule in the immune system. Mol Immunol. 2001;3:989–95. PubMed

Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, basic FGF, TGF β-1 and IL-1α messenger RNA production in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:1756–65. PubMed

Sakamoto S, Inada K. Human corneal epithelial, stromal and endothelial cells produce IL-6. Acta Soc Ophthalmol Jpn. 1992;96:702–9. PubMed

Yamagami H, Yamagami S, Inoki T, Amano S, Miyata K. The effect of proinflammatory cytokines on cytokine–chemokine gene expression profiles in the human corneal endothelium. Invest Ophthalmol Vis Sci. 2003;44:514–20. PubMed

Kennedy M, Kim KH, Harten B, et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci. 1997;38:2483–91. PubMed

Burbach GJ, Naik SM, Harten JB, et al. Interleukin-18 expression and modulation in human corneal epithelial cells. Curr Eye Res. 2001;23:64–8. PubMed

He GY, Mellon J, Niederkorn JY. The effect of oral immunization on corneal allograft survival. Transplantation. 1996;61:920–6. PubMed

Holáň V, Kuffová L, Zajícová A, et al. Urocanic acid enhances IL-10 production in activated CD4+ T cells. J Immunol. 1998;161:3237–41. PubMed

Hori J, Streilein JW. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium. Invest Ophthalmol Vis Sci. 2003;44:658–64. PubMed

Mi P, Gregerson DS, Kawashima H. Local regulation of immune responses: corneal endothelial cells alter T cell activation and cytokine production. Cytokine. 2000;12:253–64. PubMed

Mills CD. Molecular basis of ‘suppressor’ macrophages: arginine metabolism via the nitric oxide synthetase pathway. J Immunol. 1991;146:2719–23. PubMed

van der Veen RC, Dietlin TA, Gray JD, Gilmore W. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell Immunol. 2000;199:43–9. PubMed

Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol. 1994;12:635–73. PubMed

Sassani JW, Zagon IS, McLauglin PJ. Opioid growth factor modulation of corneal epithelium: uppers and downers. Curr Eye Res. 2003;26:249–62. PubMed

Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol. 1994;153:1982–9. PubMed

Takase H, Sugita S, Rhee DJ, et al. The presence of macrophage migration inhibitory factor in human trabecular meshwork and its upregulatory effects on the T helper 1 cytokine. Invest Ophthalmol Vis Sci. 2002;43:2691–6. PubMed

Seo SK, Gebhardt BM, Lim HY, et al. Murine keratocytes function as antigen-presenting cells. Eur J Immunol. 2001;31:3318–28. PubMed

Mo JS, Streilein JW. Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS. Eur J Immunol. 2001;31:3806–15. PubMed

Stumpf TH, Shimeld C, Easty DL, Hill TJ. Cytokine production in a murine model of recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci. 2001;42:372–8. PubMed

McClellan SA, Huang X, Barrett RP, Van Rooijen N, Hazlett LD. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance of pro- and anti-inflammatory cytokines in BALB/c mice. J Immunol. 2003;170:5219–27. PubMed

Thakur A, Xue M, Stapleton F, Lloyd AR, Wakefield D, Willcox MD. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2002;70:2187–97. PubMed PMC

Torres PF, Kijlstra A. The role of cytokines in corneal immunopathology. Ocular Immunol Inflamm. 2001;9:9–24. PubMed